LY2439821

· Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY2439821, covering 2016-05-26 to 2016-05-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY2439821 in Rheumatoid Arthritis [Phase 1]